Literature DB >> 18393843

Entry of oximes into the brain: a review.

D E Lorke1, H Kalasz, G A Petroianu, K Tekes.   

Abstract

The passage of hydrophilic drugs, such as oxime acetylcholinesterase reactivators, into the central nervous system is restricted by the blood-brain and the blood-cerebrospinal fluid barriers. The present review summarizes morphological and functional properties of the blood-brain barrier, blood-cerebrospinal fluid barrier and cerebrospinal fluid-brain interface and reviews the existing data on brain entry of oximes. Due to the virtual absence of transcytosis, lack of fenestrations and unique properties of tight junctions in brain endothelial cells, the blood-brain barrier only allows free diffusion of small lipophilic molecules. Various carriers transport hydrophilic compounds and extrude potentially toxic xenobiotics. The blood-cerebrospinal fluid barrier is formed by the choroid plexus epithelium, whose tight junctions are more permeable than those of brain endothelial cells. The major function of plexus epithelium cells is active transport of ions for the production of the cerebrospinal fluid. The cerebrospinal fluid-brain interface is not a biological barrier and allows free diffusion. However, in contrast to passage via the blood-brain barrier or the blood-cerebrospinal fluid barrier, direct penetration from the cerebrospinal fluid into the brain is very slow, since much longer distances have to be covered. A bulk flow of brain interstitial fluid and cerebrospinal fluid speeds up exchange between these two fluid compartments. Oximes, by reactivating acetylcholinesterase, are important adjunct therapeutics in organophosphate poisoning. They are very hydrophilic and therefore cannot diffuse freely into the central nervous system. Changes in brain acetylcholinesterase activity, oxime concentration and some biological effects elicited by oxime administration in the periphery indicate, however, that oximes can gain access to the brain to a certain degree, probably by carrier-mediated transport, reaching in the brain about 4-10% of their respective plasma levels. The clinical relevance of this effect is hotly debated. Possible strategies to improve brain penetration of oximes are discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18393843     DOI: 10.2174/092986708783955563

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  23 in total

1.  Cholinergic stimulation of the immune system protects against lethal infection by Salmonella enterica serovar Typhimurium.

Authors:  Maria J Fernandez-Cabezudo; Dietrich E Lorke; Sheikh Azimullah; Milena Mechkarska; Mohammed Y Hasan; Georg A Petroianu; Basel K al-Ramadi
Journal:  Immunology       Date:  2010-04-08       Impact factor: 7.397

2.  A New Class of Bi- and Trifunctional Sugar Oximes as Antidotes against Organophosphorus Poisoning.

Authors:  Ophélie Da Silva; Nicolas Probst; Christophe Landry; Anne-Sophie Hanak; Pierre Warnault; Caroline Coisne; André-Guilhem Calas; Fabien Gosselet; Charlotte Courageux; Anne-Julie Gastellier; Marilène Trancart; Rachid Baati; Marie-Pierre Dehouck; Ludovic Jean; Florian Nachon; Pierre-Yves Renard; José Dias
Journal:  J Med Chem       Date:  2022-03-07       Impact factor: 7.446

3.  Acute toxicity of organophosphorus compounds in guinea pigs is sex- and age-dependent and cannot be solely accounted for by acetylcholinesterase inhibition.

Authors:  William P Fawcett; Yasco Aracava; Michael Adler; Edna F R Pereira; Edson X Albuquerque
Journal:  J Pharmacol Exp Ther       Date:  2008-11-04       Impact factor: 4.030

4.  New therapeutic approaches and novel alternatives for organophosphate toxicity.

Authors:  Francine S Katz; Stevan Pecic; Laura Schneider; Zhengxiang Zhu; Ashley Hastings; Michal Luzac; Joanne Macdonald; Donald W Landry; Milan N Stojanovic
Journal:  Toxicol Lett       Date:  2018-03-31       Impact factor: 4.372

5.  Time-dependent changes of oxime K027 concentrations in different parts of rat central nervous system.

Authors:  Jana Zdarova Karasova; Filip Zemek; Kamil Musilek; Kamil Kuca
Journal:  Neurotox Res       Date:  2012-05-15       Impact factor: 3.911

Review 6.  Oxime-mediated reactivation of organophosphate-inhibited acetylcholinesterase with emphasis on centrally-active oximes.

Authors:  Janice E Chambers; Mary B Dail; Edward C Meek
Journal:  Neuropharmacology       Date:  2020-06-13       Impact factor: 5.250

7.  Efficacy of eight experimental bispyridinium oximes against paraoxon-induced mortality: comparison with the conventional oximes pralidoxime and obidoxime.

Authors:  S M Nurulain; D E Lorke; M Y Hasan; M Shafiullah; K Kuca; K Musilek; G A Petroianu
Journal:  Neurotox Res       Date:  2009-04-07       Impact factor: 3.911

8.  Effect of several new and currently available oxime cholinesterase reactivators on tabun-intoxicated rats.

Authors:  Jana Zdarova Karasova; Jiri Kassa; Young-Sik Jung; Kamil Musilek; Miroslav Pohanka; Kamil Kuca
Journal:  Int J Mol Sci       Date:  2008-11-14       Impact factor: 6.208

9.  Memantine and Its Combination with Acetylcholinesterase Inhibitors in Pharmacological Pretreatment of Soman Poisoning in Mice.

Authors:  Jiri Kassa; Jana Zdarova Karasova
Journal:  Neurotox Res       Date:  2021-07-22       Impact factor: 3.911

Review 10.  Oximes: Novel Therapeutics with Anticancer and Anti-Inflammatory Potential.

Authors:  Igor A Schepetkin; Mark B Plotnikov; Andrei I Khlebnikov; Tatiana M Plotnikova; Mark T Quinn
Journal:  Biomolecules       Date:  2021-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.